- Home
- VIGL vs CIK Comparison
VIGL vs CIK Comparison
Compare VIGL & CIK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIGL
- CIK
- Stock Information
- Founded
- VIGL 2020
- CIK 1987
- Country
- VIGL United States
- CIK United States
- Employees
- VIGL N/A
- CIK N/A
- Industry
- VIGL Biotechnology: Pharmaceutical Preparations
- CIK Finance/Investors Services
- Sector
- VIGL Health Care
- CIK Finance
- Exchange
- VIGL Nasdaq
- CIK Nasdaq
- Market Cap
- VIGL 134.9M
- CIK 154.6M
- IPO Year
- VIGL 2022
- CIK N/A
- Fundamental
- Price
- VIGL $8.05
- CIK $2.97
- Analyst Decision
- VIGL Buy
- CIK
- Analyst Count
- VIGL 7
- CIK 0
- Target Price
- VIGL $8.00
- CIK N/A
- AVG Volume (30 Days)
- VIGL 835.3K
- CIK 115.4K
- Earning Date
- VIGL 08-12-2025
- CIK 01-01-0001
- Dividend Yield
- VIGL N/A
- CIK 9.03%
- EPS Growth
- VIGL N/A
- CIK N/A
- EPS
- VIGL N/A
- CIK N/A
- Revenue
- VIGL N/A
- CIK N/A
- Revenue This Year
- VIGL N/A
- CIK N/A
- Revenue Next Year
- VIGL N/A
- CIK N/A
- P/E Ratio
- VIGL N/A
- CIK N/A
- Revenue Growth
- VIGL N/A
- CIK N/A
- 52 Week Low
- VIGL $1.31
- CIK $2.50
- 52 Week High
- VIGL $8.10
- CIK $3.19
- Technical
- Relative Strength Index (RSI)
- VIGL 78.77
- CIK 56.43
- Support Level
- VIGL $8.03
- CIK $2.95
- Resistance Level
- VIGL $8.07
- CIK $2.99
- Average True Range (ATR)
- VIGL 0.02
- CIK 0.03
- MACD
- VIGL -0.06
- CIK -0.00
- Stochastic Oscillator
- VIGL 37.50
- CIK 62.50
About VIGL Vigil Neuroscience Inc.
Vigil Neuroscience Inc is a clinical-stage biotechnology company engaged in improving the lives of patients, caregivers, and families affected by rare and common neurodegenerative diseases by pursuing the development of disease-modifying therapeutics to restore the vigilance of microglia. Microglia are the sentinel immune cells of the brain and play a critical role in maintaining central nervous system (CNS) health and responding to damage caused by disease. The group provides solutions for fully human monoclonal antibody and Oral small molecule TERM2 agonist.
About CIK Credit Suisse Asset Management Income Fund Inc.
Credit Suisse Asset Mgmt Income Fund Inc is a closed-end management investment company. The investment objective of the fund is to provide current income consistent with the preservation of capital. Credit Suisse serves as an investment adviser for the fund. Asset Management offers a wide range of investment products and functions across asset classes and investment styles. The division manages various regional portfolios, mutual funds, and other investment vehicles for governments, institutions, corporations and individuals.